Viewing Study NCT02992132


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-01-01 @ 9:03 AM
Study NCT ID: NCT02992132
Status: TERMINATED
Last Update Posted: 2019-03-28
First Post: 2016-12-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Sponsor: ACADIA Pharmaceuticals Inc.
Organization: